Shares of Doximity, Inc. (NASDAQ:DOCS – Get Free Report) gapped down prior to trading on Wednesday after Truist Financial lowered their price target on the stock from $33.00 to $28.00. The stock had previously closed at $32.79, but opened at $25.59. Doximity shares last traded at $26.01, with a volume of 5,334,398 shares. Other equities […]
Mirae Asset Global Investments Co. Ltd. lessened its stake in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 1.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 222,789 shares of the company’s stock after selling 3,415 shares during the quarter. Mirae […]
Doximity (NASDAQ:DOCS – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, August 8th. Analysts expect the company to announce earnings of $0.15 per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link. Doximity (NASDAQ:DOCS […]
Doximity, Inc. (NASDAQ:DOCS – Get Free Report) Director Timothy S. Cabral sold 4,714 shares of Doximity stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $34.96, for a total transaction of $164,801.44. Following the completion of the transaction, the director now owns 10,258 shares of […]
Doximity (NASDAQ:DOCS – Get Free Report) and MicroAlgo (NASDAQ:MLGO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership. Analyst Recommendations This is a breakdown of recent ratings for […]